(Date:11/20/2008)...C., and BRUSSELS, BELGIUM A team of researchers a... catholique de Louvain (UCL) has found that lactic...s. In further experiments, they discovered a new w...or cells by preventing them from delivering lactic... that low-oxygen, or hypoxic, cells cause resistan...
(Date:11/20/2008)...and MORRISTOWN, N.J., Nov. 20 /PRNewswire/ Bayer H...he Community Food Bank of New Jersey,(CFBNJ) in r...e for local,pharmaceutical companies to help rest...Photo: http://www.newscom.com/cgi-bin/prnh/200811...Internal Communications, and Anne King,manager, ...
(Date:11/20/2008)... cancer patients who underwent a mastectomy who un...onstruction, autologous tissue reconstruction prov...etic results than tissue expander and implant reco...ssue of the International Journal of Radiation On...he American Society for Therapeutic Radiology and ...
(Date:11/20/2008)...those tending Alzheimer,s relatives at risk for ho... Nov. 20 (HealthDay News) -- The stress of providi...n 25 percent of family caregivers having at least ...ths, says an Indiana University study. , It,s ...mer,s patient is difficult, but the Indiana Univer...
Breaking Medicine News(10 mins):Health News:Lactic acid found to fuel tumors 2Health News:Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governor's Plea to Help the State's Population in Need 2Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:When the Caregiver Becomes the Patient 2...hailand Prime Minister Surayud Chulanont, has defe...on of generic versions of three patented drugs-in...ghts in the kingdom. "We still defend what we hav...ur action to other countries as well the world com...
...d every old man that visits a doc, there is a woma...man and a woman, being the inspiration for succes...or, that too by a woman, a new survey has revealed...ife, daughter or even a female friend. A News pol...
...any Australians taking to the bottle is not funny....ottle neck in the health system, overburdened by ...eoples health. Binge drinking has become a trend..., boundaries and cultural lines. Experts have sugg...
...ing heavy amounts of alcohol over a long period of...arch that will be presented at the American Academ...pril 28 May 5, 2007. The study involved MRI scan...m Offspring study, ages 34 to 88, who were classif...
Other Medicine News:Health News:Thailand Unfazed As US Worries Over Copyright Violations 2Health News:Drinking Heavy Amounts of Alcohol Shrinks Your Brain 2(Date:11/20/2008)...ata from a prospective,registry presented this we...reatment with the Trellis(R) Peripheral Infusion S...A) successfully breaks up the blood clot in most,...que, called isolated pharmacomechanical thrombolys...han current catheter-directed thrombolysis,(CDT) ...
(Date:11/19/2008)...l significance , , ISELIN, N.J., Nov. 19 /...aq: PARS ) today announced results from its Phas...E) drug delivery technology formulated with 3% Dic...r, randomized, double-blinded, placebo-controlled ...pany,s 3% Diclofenac Diethanolamine NanoEmulsion c...
(Date:11/18/2008)...- NeuroDiscovery Ltd (ASX:,NDL), a specialty neur...pany,and Sosei Group Corporation ("Sosei"; TSE M...harmaceutical company, today announce that NeuroSo...l efficacy data for NSL-043/SD118.,This investiga... pain and has,successfully completed Phase I clin...
(Date:11/18/2008)..., elderly AML patients , , PRINCETON, N.J.,...oday announced that the first patient has been tre...-351 (Cytarabine:Daunorubicin) Liposome Injection ...kemia (AML). , , The first patient was enro...lege of Cornell University and New York Presbyter...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3First documented case of pest resistance to biotech cotton 3136 1First documented case of pest resistance to biotech cotton 3136 2First documented case of pest resistance to biotech cotton 3136 3Eat up all of your Brussels sprouts unless youre an aphid 2159 1Eat up all of your Brussels sprouts unless youre an aphid 2159 2Susan G Komen for the Cure 28R 29 Hosts Annual Affiliate Leadership Conference in Dallas 11369 1Susan G Komen for the Cure 28R 29 Hosts Annual Affiliate Leadership Conference in Dallas 11369 2Susan G Komen for the Cure 28R 29 Hosts Annual Affiliate Leadership Conference in Dallas 11369 3Grubb 26 Ellis Healthcare REIT Acquires Medical Portfolio 1 11366 1Grubb 26 Ellis Healthcare REIT Acquires Medical Portfolio 1 11366 2Grubb 26 Ellis Healthcare REIT Acquires Medical Portfolio 1 11366 3Grubb 26 Ellis Healthcare REIT Acquires Medical Portfolio 1 11366 4...K HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - N...ay announced that,detailed results from the Compan...gn prostatic hyperplasia (BPH) will be presented a...nning in September,at the South Central American U... These independent podium presentations will be,gi...
... and REGENSBURG - June 21, 2007 - “In anapla...ually clearly superior,to temozolomide,” Pro...nia, U.S.A. commented on the international Phase,I...nder development,by Antisense Pharma. Prof. Wong d...scussion session on central nervous system tumors,...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: